SCHEMBL24447710

SCHEMBL24447710

c1cnc2cc(-c3cnc4cc[nH]c4c3)oc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.47
▸ PIK3C3 Q8NEB9 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CHRM5 P08912 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ADRA2A P08913 1/20 0.37
▸ CHRNB2 P17787 1/20 0.36
▸ CHRNA4 P43681 1/20 0.36
▸ QPCT Q16769 1/20 0.36
▸ QPCTL Q9NXS2 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21312797 0.88 BRD4 (0.38) BRD4PIK3C3CHRM2CHRM4CHRM5
SCHEMBL25515225 0.84 BRD4 (0.37) BRD4PIK3C3LRRK2MAP3K12
SCHEMBL21191611 0.75 ALOX5AP (0.35) BRD4CHRM2CHRM4CHRM5CHRM1
SCHEMBL28428414 0.74 CHRM2 (0.55) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9430009 0.73 CYP1B1 (0.50) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL31283847 0.71 CHRM2 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL15730145 0.70 BRD4 (0.53) BRD4PIK3C3QPCTQPCTLLRRK2
SCHEMBL24067772 0.70 BRD4 (0.47) BRD4PIK3C3QPCTQPCTLLRRK2
SCHEMBL18363124 0.70 AXL (0.54) BRD4PIK3C3NPC1RAB9ASMN1; SMN2
SCHEMBL7848655 0.69 CHRM2 (0.51) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4001279-A1 NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS Enanta Pharmaceuticals, Inc. (US) 2022-05-25 — — EP disclosed
Send feedback